Abstract:Background: Diagnosis of primary diffuse large B-cell lymphoma of the central nervous system (PCNSL) is challenging and often delayed. MRI imaging, CSF cytology and flow cytometry have a low sensitivity and even brain biopsies can be misleading. We report three cases of PCNSL with various clinical presentation and radiological findings where the diagnosis was suggested by novel CSF biomarkers and subsequently confirmed by brain biopsy or autopsy. Case presentations: The first case is a 79-year-old man with severe neurocognitive dysfunction and static ataxia evolving over 5 months. Brain MRI revealed a nodular ventriculitis. An open brain biopsy was inconclusive. The second case is a 60-year-old woman with progressive sensory symptoms in all four limbs, evolving over 1 year. Brain and spinal MRI revealed asymmetric T2 hyperintensities of the corpus callosum, corona radiata and corticospinal tracts. The third case is a 72-year-old man recently diagnosed with primary vitreoretinal lymphoma of the right eye. A follow-up brain MRI performed 4 months after symptom onset revealed a T2 hyperintense fronto-sagittal lesion, with gadolinium uptake and perilesional edema. In all three cases, CSF flow cytometry and cytology were negative. Mutation analysis on the CSF (either by digital PCR or by next generation sequencing) identified the MYD88 L265P hotspot mutation in all three cases. A B-cell clonality study, performed in case 1 and 2, identified a monoclonal rearrangement of the immunoglobulin light chain lambda (IGL) and kappa (IGK) gene. CSF CXCL-13 and IL-10 levels were high in all three cases, and IL-10/IL-6 ratio was high in two. Diagnosis of PCNSL was later confirmed by autopsy in case 1, and by brain biopsy in case 2 and 3. Conclusions: Taken together, 5 CSF biomarkers (IL-10, IL-10/IL-6 ratio, CXCL13, MYD88 mutation and monoclonal IG gene rearrangements) were strongly indicative of a PCNSL. Using innovative CSF biomarkers can be sensitive and complementary to traditional CSF analysis and brain biopsy in the diagnosis of PCNSL, potentially allowing for earlier diagnosis and treatment.

Reliable intraoperative diagnostic methods for PCNSL: utility of combining intraoperative immunohistochemistry, cytology, and flow cytometry in achieving optimal treatment

Usefulness of intraoperative rapid immunohistochemistry in the surgical treatment of brain tumors

Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre.

The utilization of cytology for intraoperative diagnosis of primary central nervous system lymphoma

Liquid Biopsy and Other Non-Invasive Diagnostic Measures in PCNSL

Fast intraoperative detection of primary CNS lymphoma and differentiation from common CNS tumors using stimulated Raman histology and deep learning

Rapid immunocytochemistry based on alternating current electric field using squash smear preparation of central nervous system tumors

Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases

Rapid detection of the MYD88 L265P mutation for pre‐ and intra‐operative diagnosis of primary central nervous system lymphoma

Nimg-18. Rapid Intraoperative Differentiation Of Primary Cns Lymphoma From Common Cns Tumors Using Stimulated Raman Histology And Deep Learning

Cell-Block cytology in diagnosis of primary central nervous system lymphoma

Challenges in the management of primary central nervous system lymphoma

Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry

BIOM-54. A RAPID GENOTYPING PANEL FOR SENSITIVE AND SPECIFIC SEGREGATION OF CNS PATHOLOGIES

Primary diffuse large B-cell lymphoma of the central nervous system identified with CSF biomarkers

Current and emerging therapies for primary central nervous system lymphoma

Survival outcomes and treatment experience of 124 patients with primary central nervous system lymphoma

Interpretation of NCCN clinical practice guidelines for primary central nervous system lymphoma

Diagnostics and treatment delay in primary central nervous system lymphoma: What the neurosurgeon should know

Use of fluorescein sodium to obtain histological diagnosis of primary Central nervous system lymphoma ghost tumour despite disappearance on intraoperative magnetic resonance imaging: technical note and review of the literature

Advances in the Diagnosis and Treatment of Primary Central Nervous System Lymphoma